S&P 5007,722.60▲0.6% Nasdaq26,477.81▲1.2% Dow52,377.57▲0.0% Russell 2K2,818.87▲1.2% 10-Yr4.99%+1bp VIX17.52−0.87 WTI$100.46▼1.3% Gold$4,079.60▲1.0% EUR/USD1.113▼0.4% BTC$76,987▼1.0% Nikkei64,131▲3.1%
At close · Wed, Oct 28, 2026
Daily Market Updates.

Earnings

Home›Earnings›Results›We're raising our price target on Eli Lilly as the obe…

We're raising our price target on Eli Lilly as the obesity-drug boom rolls on

The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.

More like this

Sources

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.